Oral Treatment For Eczema and Psoriasis
Published November 4, 2013
US 8,535,696 B2; Lypanosys Pte Limited, Singapore, has been awarded a US patent covering a method of treatment of eczema in a mammal. It is comprised of administering an effective amount of an oral medicament consisting of cetyl myristate and/or an excipient and a diluent.
blog comments powered by Disqus